ALGS logo

Aligos Therapeutics, Inc.

ALGS
Healthcare|Biotechnology|US
$4.07
-0.44 (-9.76%)
DCF Value
$0.13
Tangible Book / Share
$1.08
Cash / Share
$2.97
Next Earnings Report
Mar 4, 2027
EPS est. -$1.91 · Revenue est. $537.5K
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (1)

Mar 2027
Est. completion
P2Chronic Hepatitis B Infection
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)
NCT06963710n=200

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Jul 2025
P1
A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers
NCT06672900

Recent Press Releases

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
Nov 6, 2026 · GlobeNewsWire
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
Nov 5, 2026 · GlobeNewsWire
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
Oct 5, 2026 · GlobeNewsWire
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
Sep 2, 2026 · GlobeNewsWire
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Aug 12, 2026 · GlobeNewsWire

SEC Filings (61)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 202610-QQuarterly reportDocumentIndex
Nov 6, 20268-KMaterial eventDocumentIndex
Sep 15, 20268-KMaterial eventDocumentIndex
Aug 6, 2026S-8Employee stock planDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jun 26, 20268-KMaterial eventDocumentIndex
Jun 24, 2026SC 13DActivist / 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 21, 20268-KMaterial eventDocumentIndex
Apr 14, 20268-KMaterial eventDocumentIndex
Mar 5, 2026S-8Employee stock planDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 4, 20268-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 6, 2025S-8Employee stock planDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Jun 26, 20258-KMaterial eventDocumentIndex
May 15, 2025SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2025SC 13GPassive 5%+ stakeDocumentIndex
May 6, 202510-QQuarterly reportDocumentIndex
May 6, 20258-KMaterial eventDocumentIndex
Apr 28, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 28, 2025ARSAnnual report to holdersDocumentIndex